nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—Azotaemia—Mechlorethamine—lymphatic system cancer	0.0435	0.0435	CcSEcCtD
Diazoxide—Haemoglobin decreased—Fludarabine—lymphatic system cancer	0.0218	0.0218	CcSEcCtD
Diazoxide—Azotaemia—Carmustine—lymphatic system cancer	0.018	0.018	CcSEcCtD
Diazoxide—Azotaemia—Vincristine—lymphatic system cancer	0.0172	0.0172	CcSEcCtD
Diazoxide—Haemoglobin decreased—Mitoxantrone—lymphatic system cancer	0.013	0.013	CcSEcCtD
Diazoxide—Ileus—Vincristine—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Diazoxide—Scotoma—Carmustine—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Diazoxide—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Diazoxide—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Diazoxide—Drug interaction—Carmustine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Diazoxide—Drug interaction—Vincristine—lymphatic system cancer	0.00988	0.00988	CcSEcCtD
Diazoxide—Sweating—Teniposide—lymphatic system cancer	0.00915	0.00915	CcSEcCtD
Diazoxide—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00906	0.00906	CcSEcCtD
Diazoxide—Haemoglobin—Teniposide—lymphatic system cancer	0.00861	0.00861	CcSEcCtD
Diazoxide—Haemorrhage—Teniposide—lymphatic system cancer	0.00857	0.00857	CcSEcCtD
Diazoxide—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.00849	0.00849	CcSEcCtD
Diazoxide—Azotaemia—Methotrexate—lymphatic system cancer	0.00835	0.00835	CcSEcCtD
Diazoxide—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00809	0.00809	CcSEcCtD
Diazoxide—Haematuria—Fludarabine—lymphatic system cancer	0.008	0.008	CcSEcCtD
Diazoxide—Flushing—Teniposide—lymphatic system cancer	0.00795	0.00795	CcSEcCtD
Diazoxide—Anorexia—Mechlorethamine—lymphatic system cancer	0.00787	0.00787	CcSEcCtD
Diazoxide—Haemoglobin—Fludarabine—lymphatic system cancer	0.00757	0.00757	CcSEcCtD
Diazoxide—Haemorrhage—Fludarabine—lymphatic system cancer	0.00753	0.00753	CcSEcCtD
Diazoxide—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00718	0.00718	CcSEcCtD
Diazoxide—Diplopia—Carmustine—lymphatic system cancer	0.00697	0.00697	CcSEcCtD
Diazoxide—Leukopenia—Teniposide—lymphatic system cancer	0.00668	0.00668	CcSEcCtD
Diazoxide—Hypertension—Teniposide—lymphatic system cancer	0.00644	0.00644	CcSEcCtD
Diazoxide—Chest pain—Teniposide—lymphatic system cancer	0.00635	0.00635	CcSEcCtD
Diazoxide—Hypokalaemia—Carmustine—lymphatic system cancer	0.00634	0.00634	CcSEcCtD
Diazoxide—Oedema—Teniposide—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Diazoxide—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Diazoxide—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00608	0.00608	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Diazoxide—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00596	0.00596	CcSEcCtD
Diazoxide—Tachycardia—Teniposide—lymphatic system cancer	0.00594	0.00594	CcSEcCtD
Diazoxide—Malaise—Fludarabine—lymphatic system cancer	0.00591	0.00591	CcSEcCtD
Diazoxide—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.0059	0.0059	CcSEcCtD
Diazoxide—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Diazoxide—Leukopenia—Fludarabine—lymphatic system cancer	0.00587	0.00587	CcSEcCtD
Diazoxide—Haematuria—Bleomycin—lymphatic system cancer	0.00587	0.00587	CcSEcCtD
Diazoxide—Pruritus—Mechlorethamine—lymphatic system cancer	0.00584	0.00584	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00583	0.00583	CcSEcCtD
Diazoxide—Anorexia—Teniposide—lymphatic system cancer	0.0058	0.0058	CcSEcCtD
Diazoxide—Hypotension—Teniposide—lymphatic system cancer	0.00569	0.00569	CcSEcCtD
Diazoxide—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00565	0.00565	CcSEcCtD
Diazoxide—Haemoglobin—Bleomycin—lymphatic system cancer	0.00555	0.00555	CcSEcCtD
Diazoxide—Haemorrhage—Bleomycin—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Diazoxide—Discomfort—Fludarabine—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Diazoxide—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00543	0.00543	CcSEcCtD
Diazoxide—Oedema—Fludarabine—lymphatic system cancer	0.00535	0.00535	CcSEcCtD
Diazoxide—Decreased appetite—Teniposide—lymphatic system cancer	0.00529	0.00529	CcSEcCtD
Diazoxide—Vomiting—Mechlorethamine—lymphatic system cancer	0.00525	0.00525	CcSEcCtD
Diazoxide—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00524	0.00524	CcSEcCtD
Diazoxide—Rash—Mechlorethamine—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Diazoxide—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Diazoxide—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Diazoxide—Flushing—Bleomycin—lymphatic system cancer	0.00513	0.00513	CcSEcCtD
Diazoxide—Anorexia—Fludarabine—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Diazoxide—Weight increased—Mitoxantrone—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Diazoxide—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00505	0.00505	CcSEcCtD
Diazoxide—Feeling abnormal—Teniposide—lymphatic system cancer	0.00502	0.00502	CcSEcCtD
Diazoxide—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00498	0.00498	CcSEcCtD
Diazoxide—Sweating—Vincristine—lymphatic system cancer	0.00492	0.00492	CcSEcCtD
Diazoxide—Nausea—Mechlorethamine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Diazoxide—Haemoglobin—Carmustine—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Diazoxide—Haemorrhage—Carmustine—lymphatic system cancer	0.00482	0.00482	CcSEcCtD
Diazoxide—Abdominal pain—Teniposide—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Diazoxide—Body temperature increased—Teniposide—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Diazoxide—Paraesthesia—Fludarabine—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Diazoxide—Sweating—Mitoxantrone—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Diazoxide—Haematuria—Mitoxantrone—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Diazoxide—Decreased appetite—Fludarabine—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Diazoxide—Pain—Fludarabine—lymphatic system cancer	0.00458	0.00458	CcSEcCtD
Diazoxide—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Diazoxide—Hypersensitivity—Teniposide—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Diazoxide—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Diazoxide—Flushing—Carmustine—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Diazoxide—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Diazoxide—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Diazoxide—Asthenia—Teniposide—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Diazoxide—Malaise—Bleomycin—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Diazoxide—Pruritus—Teniposide—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Diazoxide—Leukopenia—Bleomycin—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Diazoxide—Body temperature increased—Fludarabine—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Diazoxide—Diarrhoea—Teniposide—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Diazoxide—Chest pain—Bleomycin—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Diazoxide—Discomfort—Bleomycin—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Diazoxide—Vision blurred—Carmustine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Diazoxide—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Diazoxide—Oedema—Bleomycin—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Diazoxide—Vomiting—Teniposide—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Diazoxide—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Diazoxide—Asthenia—Fludarabine—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Diazoxide—Rash—Teniposide—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Diazoxide—Dermatitis—Teniposide—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Diazoxide—Headache—Teniposide—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Diazoxide—Pruritus—Fludarabine—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Diazoxide—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Diazoxide—Leukopenia—Carmustine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Diazoxide—Anorexia—Bleomycin—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Diazoxide—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Diazoxide—Hypotension—Bleomycin—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Diazoxide—Diarrhoea—Fludarabine—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Diazoxide—Hypertension—Carmustine—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Diazoxide—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Diazoxide—Nausea—Teniposide—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Diazoxide—Leukopenia—Vincristine—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Diazoxide—Chest pain—Carmustine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Diazoxide—Anxiety—Carmustine—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Diazoxide—Paraesthesia—Bleomycin—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Diazoxide—Malaise—Mitoxantrone—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Diazoxide—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Diazoxide—Hypertension—Vincristine—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Diazoxide—Oedema—Carmustine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Diazoxide—Decreased appetite—Bleomycin—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Diazoxide—Vomiting—Fludarabine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Diazoxide—Rash—Fludarabine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Diazoxide—Dermatitis—Fludarabine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Diazoxide—Hypertension—Mitoxantrone—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Diazoxide—Pain—Bleomycin—lymphatic system cancer	0.00336	0.00336	CcSEcCtD
Diazoxide—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Diazoxide—Headache—Fludarabine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Diazoxide—Tachycardia—Carmustine—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Diazoxide—Chest pain—Mitoxantrone—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Diazoxide—Anxiety—Mitoxantrone—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Diazoxide—Discomfort—Mitoxantrone—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Diazoxide—Oedema—Vincristine—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Diazoxide—Anorexia—Carmustine—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Diazoxide—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Diazoxide—Thrombocytopenia—Vincristine—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Diazoxide—Hypotension—Carmustine—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Diazoxide—Oedema—Mitoxantrone—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Diazoxide—Nausea—Fludarabine—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Diazoxide—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Diazoxide—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Diazoxide—Anorexia—Vincristine—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Diazoxide—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Diazoxide—Body temperature increased—Bleomycin—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Diazoxide—Insomnia—Carmustine—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Diazoxide—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Diazoxide—Paraesthesia—Carmustine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Diazoxide—Hypotension—Vincristine—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Diazoxide—Anorexia—Mitoxantrone—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Diazoxide—Decreased appetite—Carmustine—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Diazoxide—Hypotension—Mitoxantrone—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Diazoxide—Insomnia—Vincristine—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Diazoxide—Paraesthesia—Vincristine—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Diazoxide—Pain—Carmustine—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Diazoxide—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Diazoxide—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Diazoxide—Decreased appetite—Vincristine—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Diazoxide—Feeling abnormal—Carmustine—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Diazoxide—Asthenia—Bleomycin—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Diazoxide—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Diazoxide—Pain—Vincristine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Diazoxide—Pruritus—Bleomycin—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Diazoxide—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Diazoxide—Eosinophilia—Methotrexate—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Diazoxide—Pancreatitis—Methotrexate—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Diazoxide—Pain—Mitoxantrone—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Diazoxide—Abdominal pain—Carmustine—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Diazoxide—Body temperature increased—Carmustine—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Diazoxide—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Diazoxide—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Diazoxide—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Diazoxide—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Diazoxide—Abdominal pain—Vincristine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Diazoxide—Body temperature increased—Vincristine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Diazoxide—Hypersensitivity—Carmustine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Diazoxide—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Diazoxide—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Diazoxide—Vomiting—Bleomycin—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Diazoxide—Rash—Bleomycin—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Diazoxide—Dermatitis—Bleomycin—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Diazoxide—Asthenia—Carmustine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Diazoxide—Hypersensitivity—Vincristine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Diazoxide—Sweating—Methotrexate—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Diazoxide—Haematuria—Methotrexate—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Diazoxide—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Diazoxide—Asthenia—Vincristine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Diazoxide—Diarrhoea—Carmustine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Diazoxide—Nausea—Bleomycin—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Diazoxide—Asthenia—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Diazoxide—Dizziness—Carmustine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Diazoxide—Haemoglobin—Methotrexate—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Diazoxide—Diarrhoea—Vincristine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Diazoxide—Haemorrhage—Methotrexate—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Diazoxide—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Diazoxide—Vomiting—Carmustine—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Diazoxide—Dizziness—Vincristine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Diazoxide—Rash—Carmustine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Diazoxide—Dermatitis—Carmustine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Diazoxide—Headache—Carmustine—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Diazoxide—Vomiting—Vincristine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Diazoxide—Rash—Vincristine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Diazoxide—Dermatitis—Vincristine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Diazoxide—Headache—Vincristine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Diazoxide—Nausea—Carmustine—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Diazoxide—Vomiting—Mitoxantrone—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Diazoxide—Rash—Mitoxantrone—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Diazoxide—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Diazoxide—Headache—Mitoxantrone—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Diazoxide—Nausea—Vincristine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Diazoxide—Nausea—Mitoxantrone—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Diazoxide—Vision blurred—Methotrexate—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Diazoxide—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Diazoxide—Malaise—Methotrexate—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Diazoxide—Leukopenia—Methotrexate—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Diazoxide—Chest pain—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Diazoxide—Discomfort—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Diazoxide—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Diazoxide—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Diazoxide—Anorexia—Methotrexate—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Diazoxide—Hypotension—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Diazoxide—Insomnia—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Diazoxide—Paraesthesia—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Diazoxide—Decreased appetite—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Diazoxide—Pain—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Diazoxide—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Diazoxide—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Diazoxide—Abdominal pain—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Diazoxide—Body temperature increased—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Diazoxide—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Diazoxide—Asthenia—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Diazoxide—Pruritus—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Diazoxide—Diarrhoea—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Diazoxide—Dizziness—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Diazoxide—Vomiting—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Diazoxide—Rash—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Diazoxide—Dermatitis—Methotrexate—lymphatic system cancer	0.000999	0.000999	CcSEcCtD
Diazoxide—Headache—Methotrexate—lymphatic system cancer	0.000994	0.000994	CcSEcCtD
Diazoxide—Nausea—Methotrexate—lymphatic system cancer	0.000942	0.000942	CcSEcCtD
